TABLE III.
Osteoblast and Osteoclast Densities Measured with Immunohistochemical Analysis
| Mean (95% CI) |
P Value (ANOVA)* |
||||
| Vehicle Group | iPTH Group | Treatment | Duration | Treatment*Duration | |
| No. of osteoblasts/area (mm−2) | 0.002 | 0.005 | N.S. | ||
| Wk 1 | 406 (213, 599) | 640 (402, 878) | |||
| Wk 2 | 281 (162, 399) | 495 (363, 627) | |||
| No. of osteoclasts/area (mm−2) | 0.038 | 0.047 | N.S. | ||
| Wk 1 | 66.4 (26.0, 107) | 71.4 (45.9, 96.9) | |||
| Wk 2 | 69.9 (38.6, 101) | 129 (86.2, 171) | |||
N.S. = not significant.